Morningstar's Jeremy Glaser comments on hot valuations in private tech firms, scenarios at St. Joe, more movement in M&A, inflation flags, and more.
A depressed housing market has capped job growth thus far, but ultimate improvement there could help extend the recovery longer than usual, says Morningstar's Bob Johnson.
High levels of merger and acquisition activity will be the big theme of year for biotech, says Morningstar's Lauren Migliore.
Morningstar's Christine Benz discusses current pockets of opportunity with director of ETF research Scott Burns, dividend strategist Josh Peters, and associate director of fixed-income fund analysis Miriam Sjoblom.
The good news for the merger and acquisitions market in 2012? Corporate profit margins have soared.
©2012 Morningstar Advisor. All right reserved.